Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection
- PMID: 31954394
- PMCID: PMC6969976
- DOI: 10.1186/s12929-020-0617-7
Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection
Abstract
Acinetobacter baumannii (A. baumannii) is an important opportunistic pathogen causing serious nosocomial infections, which is considered as the most threatening Gram-negative bacteria (GNB). Outer membrane protein A (OmpA), a major component of outer membrane proteins (OMPs) in GNB, is a key virulence factor which mediates bacterial biofilm formation, eukaryotic cell infection, antibiotic resistance and immunomodulation. The characteristics of OmpA in Escherichia coli (E. coli) have been extensively studied since 1974, but only in recent years researchers started to clarify the functions of OmpA in A. baumannii. In this review, we summarized the structure and functions of OmpA in A. baumannii (AbOmpA), collected novel therapeutic strategies against it for treating A. baumannii infection, and emphasized the feasibility of using AbOmpA as a potential therapeutic target.
Keywords: A. baumannii; AbOmpA; Infection; Multidrug-resistant; Therapeutic target.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Ma MY, Xu J, Yu N, Huang GM. Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25:686–689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
